3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
3
Status
Completed
2
Recruiting
1
Sponsor Class
OTHER
3
Study Type
Interventional
3
Sponsor
Cancer Type
Breast
12
Gastrointestinal
11
Genitourinary
8
Thoracic
6
Other hematologic neoplasm
3
Lymphoid
3
Plasma cell
1
Head & Neck
1
Endocrine
1
CNS
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
354
Hematologic Neoplasms
272
Leukemia, Myeloid, Acute
255
Leukemia
234
Lymphoma
127
Leukemia, Lymphocytic, Chronic, B-Cell
110
Multiple Myeloma
108
Neoplasms
95
Myelodysplastic Syndromes
95
Lymphoma, Non-Hodgkin
94
Hodgkin Disease
76
Burkitt Lymphoma
64
Lymphoma, Mantle-Cell
61
Lymphoma, Follicular
60
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
60
Lymphoma, Large B-Cell, Diffuse
56
Myeloproliferative Disorders
54
Lymphoma, B-Cell, Marginal Zone
53
Lymphoma, Large-Cell, Immunoblastic
47
Congenital Abnormalities
47
Motor Activity
45
Leukemia, Myeloid, Chronic-Phase
45
Primary Myelofibrosis
43
Lymphoma, T-Cell, Cutaneous
43
Recurrence
41
Sezary Syndrome
39
Mycosis Fungoides
39
Leukemia, Myeloid, Accelerated Phase
38
Neoplasms, Plasma Cell
35
Breast Neoplasms
35
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Phase NA
×
Communication
×
Other hematologic neoplasm
×
Clear all
NCT05335369
2026-05-11
UR-GOAL 2
University of Rochester
Phase NA
Completed
161 enrolled
19 charts
NCT06102330
2025-08-03
HomeVENT
Johns Hopkins University
Phase NA
Recruiting
600 enrolled
NCT06376188
2024-04-19
SimCom
Medical University of Vienna
Phase NA
Completed
46 enrolled